Cohen-Solal A, Baleynaud S, Laperche T, Sebag C, Gourgon R
Service de Cardiologie, Hôpital Bichat, Beaujon, Clichy, France.
J Cardiovasc Pharmacol. 1993 Jul;22(1):33-8. doi: 10.1097/00005344-199307000-00006.
The effects of beta-blockers and calcium-channel blockers on cardiopulmonary response during exercise are not well characterized. Sixteen sedentary patients with essential hypertension underwent a randomized, double-blind, cross-over study comparing atenolol and diltiazem sustained-release 300 mg, each administered during 6 weeks, after a 15-day run-in placebo period. Neither atenolol nor diltiazem significantly affected maximal exercise duration, maximal oxygen uptake, ventilatory threshold, or any of the ventilatory parameters during exercise. With atenolol, the maximal oxygen pulse was significantly increased and compensated for the decrease in heart rate during exercise. Atenolol and diltiazem do not limit maximal exercise tolerance in untrained hypertensive subjects, but the circulatory profile is more preserved with diltiazem.
β受体阻滞剂和钙通道阻滞剂对运动期间心肺反应的影响尚未得到充分阐明。16例久坐不动的原发性高血压患者进行了一项随机、双盲、交叉研究,比较了阿替洛尔和300mg缓释地尔硫䓬,在15天的导入安慰剂期后,每种药物各给药6周。阿替洛尔和地尔硫䓬均未显著影响最大运动持续时间、最大摄氧量、通气阈值或运动期间的任何通气参数。使用阿替洛尔时,最大氧脉搏显著增加,并补偿了运动期间心率的下降。阿替洛尔和地尔硫䓬不会限制未经训练的高血压受试者的最大运动耐力,但地尔硫䓬能更好地维持循环状态。